![]() | Up a level |
Rahmani, F. and Asgharzadeh, F. and Avan, A. and Barneh, F. and Parizadeh, M. R. and Ferns, G. A. and Ryzhikov, M. and Ahmadian, M. R. and Giovannetti, E. and Jafari, M. and Khazaei, M. and Hassanian, S. M. (2020) Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways. Life Sciences, 249.